We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Combination Chemotherapy and Bevacizumab Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Updated: 1/1/1970
A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases
Status: Archived
Updated: 1/1/1970
Laser Based Focal Ablation of Low Grade Prostate Cancer
A Pilot Study to Evaluate Magnetic Resonance Thermal Image-guided Laser-Induced Interstitial Thermal Therapy for Focal Ablation of Prostate Cancer
Status: Archived
Laser Based Focal Ablation of Low Grade Prostate Cancer
Updated: 1/1/1970
A Pilot Study to Evaluate Magnetic Resonance Thermal Image-guided Laser-Induced Interstitial Thermal Therapy for Focal Ablation of Prostate Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Updated: 1/1/1970
.A Neoadjuvant Pharmacodynamic Study Of RO4929097 (RO) in Pancreas Cancer
Status: Archived
Updated: 1/1/1970